OPX Biotechnologies

In my third part of my 3 part Q & A with Charles Eggert, CEO of OPX Biotechnologies, he discusses the current state of affairs in the biofuels industry and policy.

ROBERT GLUCK:  How do you view the current state of affairs of the American biofuels industry? Biochemicals industry?

OPX Biotechnologies has received $17.5 million from investors to continue its development of bioacrylic and biodiesel.

 

Syndicate content
EnergyBoom Community

Welcome to EnergyBoom - an online community that is actively shaping the most important debate of our time. Login or register to get started.

E•B Clean 100
Choose a different index from the list below.
Trending Story